| Product NDC: | 0053-7596 |
| Proprietary Name: | Vivaglobin |
| Non Proprietary Name: | Human Immunoglobulin G |
| Active Ingredient(s): | 160 mg/mL & nbsp; Human Immunoglobulin G |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0053-7596 |
| Labeler Name: | CSL Behring LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125115 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20060109 |
| Package NDC: | 0053-7596-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0053-7596-01) > 3 mL in 1 VIAL, SINGLE-USE |
| NDC Code | 0053-7596-01 |
| Proprietary Name | Vivaglobin |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0053-7596-01) > 3 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0053-7596 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Human Immunoglobulin G |
| Dosage Form Name | SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20060109 |
| Marketing Category Name | BLA |
| Labeler Name | CSL Behring LLC |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Strength Number | 160 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |